![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 15, 10421-10429, April 9, 1999
From the Department of Biosciences at Novum, The nuclear orphan receptor OR1 has been shown to
bind as a heterodimer with retinoid X receptor (RXR) to direct repeat 4 (DR4) response elements. It remained unclear, however, whether this
represents the only or the optimal binding site for this receptor.
Therefore, we performed a DNA binding site selection assay that allows
the identification of novel DNA binding sites for OR1 in an unbiased
manner. While OR1 alone was not able to select a specific sequence from
the pool of oligonucleotides, the OR1/RXR heterodimer selected a highly
conserved DR1 element, termed DR1s, with two AGGTCA motifs spaced by
one adenosine. The functional activity of the consensus binding site
was verified in transient transfection assays and corroborated by
in vitro studies. Based on the sequence of the consensus
DR1s, we located putative natural binding sites in the 5'-promoter
flanking regions of the rat S14 gene and the rat cholecystokinin type A
receptor gene. Furthermore, we could show that although the OR1/RXR
heterodimer has a distinct binding orientation on a DR4 element, it is
able to bind in both orientations to the DR1s element. The OR1 paralog LXR
Identification of a Novel DNA Binding Site for Nuclear Orphan
Receptor OR1
does not bind as a heterodimer with RXR to the DR1s element, indicating that these receptors, despite their homology, are involved in the regulation of different sets of genes.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
P. Germain, P. Chambon, G. Eichele, R. M. Evans, M. A. Lazar, M. Leid, A. R. De Lera, R. Lotan, D. J. Mangelsdorf, and H. Gronemeyer International Union of Pharmacology. LXIII. Retinoid X Receptors Pharmacol. Rev., December 1, 2006; 58(4): 760 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sandelin and W. W. Wasserman Prediction of Nuclear Hormone Receptor Response Elements Mol. Endocrinol., March 1, 2005; 19(3): 595 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R Steffensen, S. Y. Neo, T. M Stulnig, V. B Vega, S. S Rahman, G. U Schuster, J.-A. Gustafsson, and E. T Liu Genome-wide expression profiling; a panel of mouse tissues discloses novel biological functions of liver X receptors in adrenals J. Mol. Endocrinol., December 1, 2004; 33(3): 609 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Caira, P. Antonson, M. Pelto-Huikko, E. Treuter, and J.-A. Gustafsson Cloning and Characterization of RAP250, a Novel Nuclear Receptor Coactivator J. Biol. Chem., February 25, 2000; 275(8): 5308 - 5317. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kassam, C. J. Winrow, F. Fernandez-Rachubinski, J. P. Capone, and R. A. Rachubinski The Peroxisome Proliferator Response Element of the Gene Encoding the Peroxisomal beta -Oxidation Enzyme Enoyl-CoA Hydratase/3-Hydroxyacyl-CoA Dehydrogenase Is a Target for Constitutive Androstane Receptor beta /9-cis-Retinoic Acid Receptor-mediated Transactivation J. Biol. Chem., February 11, 2000; 275(6): 4345 - 4350. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Costet, Y. Luo, N. Wang, and A. R. Tall Sterol-dependent Transactivation of the ABC1 Promoter by the Liver X Receptor/Retinoid X Receptor J. Biol. Chem., September 1, 2000; 275(36): 28240 - 28245. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |